Avandia

Halting Avandia Use Hikes Blood Sugar Levels

Study found diabetics who discontinued drug had less treatment, worse management of disease THURSDAY, April 16 (HealthDay News) -- Many patients who stopped using the diabetes drug rosiglitazone (Avandia) due to concerns about the drug's safety received less treatment and developed hig...

LegalView Updates Avandia Information Portal With New Articles Detailing Potentially Dangerous Side Effects

LegalView continued to maintain its newsworthy coverage on its Avandia information portal with the recent addition of several new articles detailing the drug's potentially dangerous side effects. The type 2 diabetes drug has been linked to bone fracture, osteoporosis and heart failure among pati...

Public Citizen Petitions FDA to Ban Diabetes Drug Avandia, According to Avandia Plaintiffs Attorney Group

National non-profit organization documents upsurge in negative clinical data associated with use of Avandia, urges FDA commissioner to remove drug from U.S. market immediately Mineola, N.Y. (Lexis Nexis) November 6, 2008 -- Public Citizen, a non-profit organization repr...

LegalView Re-Launches its Avandia Information Portal with News of the Type 2 Diabetes Drug's Risks and Dangers

LegalView reintroduced its Avandia practice area to include updated information for victims of the drug's side effects. Avandia has been linked to the development of early on-set osteoporosis and heart failure among patients. Denver (PRWEB) October 21, 2008 -- LegalView...

Concern From Doctors Regarding the Cardiovascular Safety of GlaxoSmithKline's Avandia Increases Nine-Fold Following Publication of Meta-Analysis

Nearly Three-Quarters of Physicians Have Switched Patients to Merck's Januvia, According to a New Report from Decision Resources WALTHAM, Mass., April 22 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, ...

Older Diabetics Using Avandia Face Increased Death Risk

Canadian study also found those over 65 more likely to have heart trouble with drug TUESDAY, Dec. 11 (HealthDay News) -- Older patients using the diabetes drug Avandia faced an increased risk of heart attack, heart failure and even death, new research shows. According to the Canadi...

Diabetes Drug Avandia Could Weaken Bones

Mouse study suggests it boosts production of bone-eroding cells MONDAY, Dec. 3 (HealthDay News) -- Avandia, a drug used by millions of diabetes patients, may contribute to bone loss, according to a new study conducted in mice. Experts fear that, over the long term, Avandia (rosigli...

Diabetes Drug Avandia Boosts Heart Risks: Study

Another study finds a similar drug, Actos, may be a better choice, researchers say TUESDAY, Sept. 11 (HealthDay News) -- A controversial drug called Avandia, used by millions of diabetics to control blood sugar, greatly increases their risk of heart attack and heart failure, researcher...

Consumer Group Seeks FDA Ban on Avandia

Public Citizen cites liver failure deaths, other risks of adverse events for diabetes drug THURSDAY, Oct. 30 (HealthDay News) -- The diabetes drug Avandia should be banned in the United States because it can cause death from liver failure and poses many other life-threatening risks th...

Controversy Spikes Over Anti-diabetes Drug Avandia

Controversy over diabetes drug Avandia heated up Wednesday as experts pointed to studies linking it to greater heart attack risk, while a GSK study claimed rosiglitazone is safe. The GlaxoSmithKline study published online Tuesday by the New England Journal of Medicine (NEJM) gave preliminary ...

Avandia in Medical Technology

Large, Long-Term Study Shows Avandia Has No Increased Overall Cardiovascular Risk Compared to Other Commonly Used Diabetes Medicines

RECORD trial also demonstrates durable blood sugar control over time with Avandia LONDON, RESEARCH TRIANGLE PARK, N.C., and NEW ORLEANS, June 5 /PRNewswire/ -- Clinical trial results presented today at the American Diabetes Association annual meeting show that overall rates of cardiovascular ...

MultiVu Video Feed: Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals Important Cardiovascular Safety News on AVANDIA

NEW YORK, June 9 /PRNewswire/ -- SATELLITE FEED: Monday, June 9th, 2008 1:00 PM - 1:15 PM ET Galaxy 26 Transponder 24 C-Band Downlink Freq: 4180 H NEWS: LARGE, LONG-TERM VETERANS AFFAIRS DIABETES TRIAL (VADT) REVEALS IMPORTANT CARDIOVASCULAR SAFETY NEWS ON AVANDIA FORMAT: ...

Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death

"Patients and physicians should find these data reassuring" PHILADELPHIA, June 05, 2007 /PRNewswire-FirstCall/ -- GlaxoSmithKline said today that findings from an interim analysis of RECORD (Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of glycemia in Diabetes), a prospective clinica...

Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)

Results show risk of heart attack comparable to two widely used diabetes medicines LONDON , June 6, 2007 - A study of more than 33,000 type 2 diabetes patients in a real-world setting was published today. This study shows that the incidence of hospitaliations for heart attack, an...

Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures

EAST HANOVER, N.J.--(BUSINESS WIRE)--Jul 11, 2007 - Since the May 2007 release of a New England Journal of Medicine (NEJM) report that Avandia users are 43 percent more likely to suffer a heart attack and 67 percent more likely to die of cardiovascular causes than non-users of Avandia, it is no sur...

FDA Issues Safety Alert on Avandia

ROCKVILLE, Md., May 21, 2007-The U.S. Food and Drug Administration (FDA) is aware of a potential safety issue related to Avandia (rosiglitazone), a drug approved to treat type 2 diabetes. Safety data from controlled clinical trials have shown that there is a potentially significant increase in the ...

Spherix Elects New Independent Director, and Elects Chairman of the Board

...ales and marketing functions, and was actively involved in the promotion of avandia and the subsequent combinations of avandia with metformin and a sulfonylurea from the time of their respective market ...

GSK Believes There Is No Liver Safety Issue With AVANDIA; Responds to Public Citizen Petition

...profile for AVANDIA. Patients being treated with avandia or other medicines to control blood sugar levels s...eir doctor advises a different course of action. avandia has been shown to be a safe and highly effective t.... GSK strongly supports the safety and efficacy of avandia based on extensive clinical trial experience and w...

FDA Updates Label for AVANDIA(R) to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years

... Data Provides Further Information on avandia as a Safe and Effective Treatment Option for...ial (ADOPT), a 4- to- 6 year head-to-head study of avandia versus metformin and glyburide monotherapy in rece...ly 15 percent with AVANDIA. The difference between avandia and the comparators was statistically significant....

Two Large, Independent Outcomes Trials Offer New Important Safety Information on Cardiovascular Effects of AVANDIA(R)

... VADT, there is no evidence to suggest that use of avandia increases the risk for CV mortality and morbidity ...rdiovascular Risk in Diabetes (ACCORD), found that avandia was not associated with any increased risk of deat...ion (ADA) in San Francisco, CA. "The findings on avandia should be reassuring to physicians who prescribe...

Avandia in Biological Technology

GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes

...the treatment of type 2 diabetes, and importantly, avandia has been shown to control blood sugar for longer t... sugar control in patients with type 2 diabetes. avandia can cause or worsen heart failure. If you have sev...y of the heart), you cannot be started on Avandia. avandia is also not recommended if you have heart failure ...

Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence

...sitions. Mr. Huang also guided strategic planning and execution for Tularik's marketing programs. Prior to Tularik, Mr. Huang was product director of avandia and diabetes at SmithKline Beecham PLC (now GlaxoSmithKline) where he launched Avandia (rosiglitazone maleate), which achieved over $2 billion in U.S....

FDA: Tortoise, hare, or something else?

...controversy would continue to grow. Indeed, the avandia issue splashed across the headlines this past mo... the system itself deserves a closer look. The avandia Failure Avandia is a drug that controls blood-...context of a condition with no symptoms. As the avandia story reached the front pages, a number of related...